Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Wondering what do you need to start investing? Discover the essential tools and knowledge required to kickstart your investment journey.
19,065 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
On Mar. 12, a niche tech partnership caused a notable move in the stock market today landscape. Ondas jumped after li...
Bitwise Asset Management will embed crypto model portfolios into Parrot Finance's retail investing app, marking a shi...
A private equity round closes March 19 for an IP rights company that reserved a Nasdaq ticker, signaling rising inves...
The market is higher in 2026, but smart investors know steady, disciplined ETF investing still pays. This guide break...
March has brought renewed volatility as Tencent Music reports mixed results, boosting questions about user metrics an...
Pipelines may not grab headlines, but their steady cash flow powers dividends for investors who plan ahead. Learn how...
Artificial intelligence stocks have powered market gains and drawn fierce interest. This guide breaks down what the d...
SpaceX headlines grab attention, but smart investors look for durable earnings growth in established aerospace player...
Snowflake stock down hard has sparked headlines and worries about growth. But the core platform—cross‑cloud data ware...
In 2025, the United States produced a surge of new millionaires, averaging roughly 1,200 per day. The trend lifted th...
A dramatic one-day move put Relay Therapeutics in the spotlight. After encouraging Phase 2 results for zovegalisib an...